Serono Responds To Infertility Discounting With Gonal-f DTC Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
Serono is aiming to offset heavy competitive discounting in the infertility treatment market through expansion of direct-to-consumer advertising and support programs for its Gonal-f therapy, the company said